Clinical Study of Tongxinluo Capsule Combined with Tirofiban in the Treatment of Acute Myocardial Infarction

目的：探讨通心络胶囊联合替罗非班治疗急性心肌梗死的临床疗效。方法：选取2021.09~2024.09本院收治得到118例急性心肌梗死患者为对象，以信封抽签法分为观察组、对照组，每组59例。对照组以替罗非班治疗，观察组联合通心络胶囊治疗。评估两组临床疗效、心功能、心肌损伤标志物、氧化应激、血管内皮功能和不良反应发生情况。结果：观察组总有效率高于对照组(P 0.05)。结论：通心络胶囊联合替罗非班治疗急性心肌梗死的临床疗效显著，可提升患者心功能，降低心肌损伤标志物水平，抑制机体的氧化应激反应水平，改善患者的血管内皮功能，治疗安全性良好。Objective: To investigate the clinical efficacy of Tongxinluo capsule combined with Tirofiban in the treatment of acute myocardial infarction. Methods: A total of 118 patients with acute myocardial infarction were selected from 2021.09 to 2024.09. They were divided into observation group and control group by envelope drawing method, with 59 cases in each group. The control group was treated with tirofiban, and the observation group was treated with Tongxinluo capsule. Clinical efficacy, cardiac function, markers of myocardial injury, oxidative stress, vascular endothelial function and occurrence of adverse reactions were evaluated in both groups. Results: The total effective rate of observation group was higher than that of control group (P 0.05). Conclusion: Tongxinluo capsule combined with Tirofiban has significant clinical efficacy in the treatment of acute myocardial infarction, which can improve the sexual function of patients, reduce the level of myocardial injury markers, inhibit the level of oxidative stress response, improve the vascular endothelial function of patients, and has good therapeutic safety.